Dr. Chaur-Jong Hu is the consultant of the Department of Neurology and Dementia Center in Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan. He is also a professor in Neurology and the Dean of the College of Medicine, Taipei Medical University, Taipei, Taiwan.

Dr. Hu obtained his medical degree from Taipei Medical University, Taipei, Taiwan in 1990. He completed the residency training in the Department of Neurology, Taipei Municipal Jen-Ai Hospital. He also has ever worked as a research fellow in the Department of Neurology, stroke center, Washington University School of Medicine, St. Louis, Missouri, USA. He established a laboratory focusing on molecular mechanisms of neurological diseases, including cell and animal researches in TMU campus. Dr Hu has extensive experience in global and domestic clinical trials of therapies for stroke, Alzheimer Disease and other neurological diseases. He has published over 300 peer-reviewed papers and 2 book chapters on the pathophysiology of ischemic injury of brain and use of botulinum toxin in neuropathic pain.

Dr Hu is currently the ex-president of the Taiwan Neurological Society and ex-president of Taiwan Dementia society. He is also a fellow of the American Heart Association (FAHA) and President of Vas-Cog Asia.

Prof. Hu is working on molecular mechanisms of neurological diseases, more focusing on Alzheimer disease (AD) and vascular dementia (VaD). In his Lab., he uses transgenic AD mouse model and VaD moue model by bilateral common carotid artery occlusion (BCCAO). His team is trying new approaches for therapy. In addition, Prof. Hu’s team has established one cohort of dementia and one cohort of post-stroke cognitive impairment. There are 4000 and over 500 patients in the cohorts respectively. The methodology in his Lab includes molecular biology, such as Western blotting, real time PCR, DNA genotyping, flow cytometry and single cell RNAseq, animal MRI, PET imaging.